These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26101559)

  • 1. Target (In)Validation: A Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry.
    Sweis RF
    ACS Med Chem Lett; 2015 Jun; 6(6):618-21. PubMed ID: 26101559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Critical Role of Organic Chemistry in Drug Discovery.
    Rotella DP
    ACS Chem Neurosci; 2016 Oct; 7(10):1315-1316. PubMed ID: 27623164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
    Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
    PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain patients' experiences of validation and invalidation from physicians before and after multimodal pain rehabilitation: Associations with pain, negative affectivity, and treatment outcome.
    Edlund SM; Wurm M; Holländare F; Linton SJ; Fruzzetti AE; Tillfors M
    Scand J Pain; 2017 Oct; 17():77-86. PubMed ID: 28850377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigating risk in academic preclinical drug discovery.
    Dahlin JL; Inglese J; Walters MA
    Nat Rev Drug Discov; 2015 Apr; 14(4):279-94. PubMed ID: 25829283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern advances in heterocyclic chemistry in drug discovery.
    Taylor AP; Robinson RP; Fobian YM; Blakemore DC; Jones LH; Fadeyi O
    Org Biomol Chem; 2016 Jul; 14(28):6611-37. PubMed ID: 27282396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "The within-person effects of validation and invalidation on in-session changes in affect,": Correction to Benitez et al. (2019).
    Personal Disord; 2019 Sep; 10(5):415. PubMed ID: 31448943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The within-person effects of validation and invalidation on in-session changes in affect.
    Benitez C; Southward MW; Altenburger EM; Howard KP; Cheavens JS
    Personal Disord; 2019 Sep; 10(5):406-415. PubMed ID: 30714798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioanalytics in medicinal chemistry: from assay development to evolutive drug design].
    Jose J
    Ann Pharm Fr; 2009 Nov; 67(6):399-407. PubMed ID: 19900603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An αv-RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities.
    Hatley RJD; Macdonald SJF; Slack RJ; Le J; Ludbrook SB; Lukey PT
    Angew Chem Int Ed Engl; 2018 Mar; 57(13):3298-3321. PubMed ID: 28944552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.
    Cohen SM
    Acc Chem Res; 2017 Aug; 50(8):2007-2016. PubMed ID: 28715203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets.
    Hardy LW; Peet NP
    Drug Discov Today; 2004 Feb; 9(3):117-26. PubMed ID: 14960389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery.
    Ottl J; Leder L; Schaefer JV; Dumelin CE
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31027189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based biomarkers in drug development.
    Miller RA; Spellman DS
    Adv Exp Med Biol; 2014; 806():341-59. PubMed ID: 24952191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass Spectrometry-Based Biomarkers in Drug Development.
    Robinson MR; Miller RA; Spellman DS
    Adv Exp Med Biol; 2019; 1140():435-449. PubMed ID: 31347063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Drug" Discovery with the Help of Organic Chemistry].
    Itoh Y; Suzuki T
    Yakugaku Zasshi; 2017; 137(3):283-292. PubMed ID: 28250322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How well do medicinal chemists learn from experience?
    Cheshire DR
    Drug Discov Today; 2011 Sep; 16(17-18):817-21. PubMed ID: 21704183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: in silico drug design and medicinal chemistry).
    Singla RK
    Curr Top Med Chem; 2015; 15(11):971-2. PubMed ID: 25860175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.